1.A correlation study on divergent thinking and creative potential of college students
Tingting LI ; Qiufang FU ; Xiaolan FU
Chinese Journal of Behavioral Medicine and Brain Science 2015;24(2):166-168
Objective To investigate characteristics and psychological mechanisms of creativity of college students by using divergent thinking tasks and creativity potential test.Methods Totally 150 college students were selected and assessed with three types of open-ended divergent thinking tasks (unusual uses task,instances task,consequences task) and the Williams Scale of the Creativity Assessment Packet (CAP) in this study.The divergent productions were scored by two independent raters on fluency,originality,flexibility dimension,and the CAP results were analyzed on risk-taking,curiosity,imagination and complexity.Results (1) The results showed that scores on fluency,flexibility,and originality correlated with each other on each of the three different divergent thinking tasks (P<0.01).(2) Scores on fluency and flexibility among the three different divergent thinking tasks significantly correlated with each other (fluency:r=0.22,P<0.01; r=0.47,P<0.01 ; r=0.26,P<0.01 ;flexibility:r=0.26,P<0.01 ; r=0.28,P<0.01 ; r=0.18,P<0.05),while the correction coefficients of scores on originality among the three tasks were not significant.(3) Most scores of fluency or flexibility of different tasks were significandy correlated with risk-taking and imagination (P<0.05),while originality was correlated with different creativity potentials on each task (originality of instances task and imagination:r=0.18,P<0.05 ; originality of consequences task and risk-taking:r=0.26,P<0.01 ; originality of unusual uses task and complexity:r=0.17,P<0.05).Conclusion The results suggest that fluency and flexibility are the general characteristics of divergent thinking,which are associated with imagination and adventure,while originality is specific nature of divergent thinking,which is associated with various creative potentials according to the tasks.
2.Role of RISK signal pathway in reducing clenbuterol-induced cardiomycytes A/R injury of neonatal rat
Qiufang ZHANG ; Yan TAN ; Xuanbin WANG ; Longrui PAN ; Hongliang LI ; Hui LIU ; Jizhou XIANG ; Qin FU
Chinese Pharmacological Bulletin 2015;(10):1368-1374
Aims To study the effects of clenbuterol on anoxia/reoxygenation( A/R) injury in neonatal Wistar rat cardiomyocytes and to explore whether its mecha-nism is related to reperfusion injury salvage kinase ( RISK) or not. Methods The cultured primary neo-natal cardiomyocytes were randomly divided into eight groups: ①normal culture group; ②anoxia/reoxygen-ation( A/R) group;③ clenbuterol ( 1 μmol · L-1 ) +A/R;④ICI118,551(10 μmol·L-1) + clenbuterol ( 1 μmol · L-1 ) + A/R; ⑤Metoprolol ( 10μmol · L-1 ) + clenbuterol(1μmol·L-1 ) + A/R group;⑥Metoprolol ( 10 μmol · L-1 ) + A/R group; ⑦PD98059 ( 20 μmol · L-1 ) + clenbuterol ( 1 μmol · L-1 ) + A/R group;⑧ LY294002(10 μmol·L-1 ) +clenbuterol(1 μmol · L-1 ) + A/R group. Cell via-bility was determined by the conventional MTT reduc-tion assay. The content of LDH in cultured medium was measured with colorimetry. Cardiomyocyte apopto-sis was determined by Hoechst33342 . Intracellular re-active species( ROS) were monitored by the fluorescent DCFH-DA. Total ERK2 and phosphorylated ERK were detected by western blot. Results Compared with A/R group, clenbuterol significantly increased vaibility of cells, reduced LDH release, lowered the rate of apop-tosis and ROS production. When addedβ2 receptor an-tagonist ICI118 , 551 , PI3 K inhibitor LY294002 and ERK inhibitor PD98059 , the effects of clenbuterol a-bove were inhibited; but β1 receptor antagonist Meto-prolol protected the cardiomyocytes from A/R injury, as evidenced by decreased LDH release and increased cell viability. There were no synergistic effects in the combined use of clenbuterol and Metoprolol. Conclu-sion clenbuterol exerts cardioprotective effects against A/R injury by inhibiting oxidative stress and apopto-sis. The protection of clenbuterol is inhibited by ICI118 , 551 , LY294002 and PD98059 . clenbuterol protects cardiomyocytes against A/R injury via RISK pathway by activation of β2 receptor.